FDA approved Adcetris (brentuximab vedotin) for adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center is now certified to offer CAR-T cell therapy.
Array BioPharma Inc. published the results of its phase III COLUMBUS trial for the treatment of patients with BRAF-mutant advanced, unresectable or metastatic melanoma were published in The Lancet Oncology.
AVEO Oncology has published the long-term follow-up results from Study 902, where patients were treated with tivozanib (Fotvda) as second-line treatment in advanced renal cell carcinoma, in the European Journal of Cancer. The publication, titled “Efficacy of Tivozanib Treatment after Sorafenib in Patients with Advanced Renal Cell Carcinoma: Crossover of a Phase 3 Study”, was published online first and is available here.
Men who take the medication finasteride get a prostate cancer prevention benefit that can last 16 years—twice as long as previously recorded, according to SWOG clinical trial analysis published in the Journal of the National Cancer Institute.
Researchers at Emory University and Northwestern University developed artificial intelligence software that can predict the survival of patients diagnosed with glioma by examining data from tissue biopsies.
Robert Redfield is expected to be named the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry.
The University of Arkansas for Medical Science will start enrollment in the state's first-ever radiation oncology residency program.
Andrew Aplin was named the first recipient of the Kalbach-Newtown professorship at Thomas Jefferson University.
Jennifer Dorazio was named assistant director for administration at WVU Cancer Institute
